AA
CDMO

Apriem Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Apriem Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1
Closed – – 653
2016
Q1 		$0 Hold
1
– – ﹤0.01% 629
2015
Q4 		$0 Buy
+1
New +$8 ﹤0.01% 572

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Apriem Advisors's CDMO Position: Q2 2016 in Review

Apriem Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2016, closing a stake of 1 share.

Apriem Advisors first reported a position in CDMO in Q4 2015 and held it in 2 quarters. The position peaked at $0 in Q1 2016. 76 funds tracked by Wall St. Rank hold CDMO as of Q2 2016.

  • Apriem Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Apriem Advisors sold 1 Avid Bioservices, Inc. Common Stock share in Q2 2016.
  • Apriem Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Apriem Advisors's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q1 2016.
  • 76 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2016.

Based on Apriem Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.